Menu Back to 9th-DIA-Labeling-Workshop-in-Japan

Overview

This workshop will be conducted in Japanese Language only.

Click Here to View the Flyer in Japanese

Program Committee

  • Asami  Ezaki, MS
    Asami Ezaki, MS Senior Reviewer, Office of Safety II / Office of New Drug V
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Yasuhiro  Honsho
    Yasuhiro Honsho Associate Director, Global Medical Writing Gr, New Drug Regulatory Affairs Dept
    Daiichi Sankyo Co., Ltd., Japan
  • Yuji  Ito
    Yuji Ito Prescribing Information Group, RA Functions Dept., Regulatory Affairs Japan
    Novartis Pharma K.K., Japan
  • Kana  Maruyama
    Kana Maruyama Manager, Labeling Group, Regulatory Compliance Department, RA Division
    Janssen Pharmaceutical K.K., Japan
  • Ken  Nakajima, RPh
    Ken Nakajima, RPh Head of Medical Safety, Pharmacovigilance Department
    Otsuka Pharmaceutical Co., Ltd., Japan
  • Yuji  Ohne
    Yuji Ohne Director, Pharmacovigilance
    SymBio Pharmaceuticals Limited, Japan
  • Keinosuke  Okazaki
    Keinosuke Okazaki Section Chief of Drug Information, Department of Pharmacy Service
    Showa University Hospital, Japan
  • Mikiko  Shitara
    Mikiko Shitara Manager, Labeling Group, RA Management, RA, Development & Medical Affairs Div.
    GlaxoSmithKline K.K., Japan
  • Rie  Matsui, RPh
    Rie Matsui, RPh Director, Regional Labeling Head for APAC, International Labeling Group
    Pfizer R&D Japan, Japan
  • Akiyoshi  Uchiyama
    Akiyoshi Uchiyama President
    Artage Inc., Japan
Load More

Contact us


Please contact DIA Japan for further information.

Send Email
+81.3.6214.0574

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download